A novel automated SARS-CoV-2 saliva PCR test protects a global asymptomatic workforce

Regular PCR testing of nasopharyngeal swabs from symptomatic individuals for SARS-CoV-2 virus has become the established method by which health services are managing the COVID-19 pandemic. Businesses such as AstraZeneca have also prioritised voluntary asymptomatic testing to keep workplaces safe and...

Full description

Saved in:

Bibliographic Details
Published in:	Scientific reports Vol. 11; no. 1; p. 12676
Main Authors:	Carter, Nikki, Clausen, Maryam, Halpin, Rebecca A., Blackmore, Colin, Cai, Kang, Delpuech, Oona, Kohlmann, Alexander, Magnusson, Otto, March, Ruth, O’Neill, Daniel, Prakash, Kasthuri, Sherwood, James, Sundin, Tabetha, Swift, Jason, Tarakameh, Azar, Wijdicks, Marilou, Wise, Daniel, Fidock, Mark
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 16-06-2021 Nature Publishing Group Nature Portfolio
Subjects:	692/4017 692/420/254 692/700/139 Asymptomatic Automation COVID-19 Humanities and Social Sciences multidisciplinary Pandemics Saliva Science Science (multidisciplinary) Severe acute respiratory syndrome coronavirus 2
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Regular PCR testing of nasopharyngeal swabs from symptomatic individuals for SARS-CoV-2 virus has become the established method by which health services are managing the COVID-19 pandemic. Businesses such as AstraZeneca have also prioritised voluntary asymptomatic testing to keep workplaces safe and maintain supply of essential medicines to patients. We describe the development of an internal automated SARS-CoV-2 testing programme including the transformative introduction of saliva as an alternative sample type.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	2045-2322 2045-2322
DOI:	10.1038/s41598-021-92070-w